Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

Becomes the first company to bring Illumina's revolutionary Genome Sequencing Technology to South Asia Launches KaryoSeq to detect genome abnormalities in Prenatal and newborn conditions FOSTER ...

In the assessment of 12-month price targets, analysts unveil insights for Illumina, presenting an average target of $105.18, a high estimate of $185.00, and a low estimate of $77.00. Observing a ...

Key players in the Whole Genome Sequencing Market profiled in the report include Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, F. Hoffmann-La Roche, Illumina ...

Illumina will join with Nashville Biosciences and Amgen’s deCODE Genetics subsidiary to whole-genome sequence the largest-ever dataset of genomes from African-Americans—approximately 35,000 ...

Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...

The era of fast, cheap genome sequencing is here Illumina just announced a machine that can crack genomes twice as fast.

Product development at Illumina has included whole-genome sequencing, a tool that can be used in diagnostics to identify the causative variant of a disease, among other applications.

Sequencing this set of samples is the first in Illumina and Nashville Biosciences' Alliance for Genomic Discovery (AGD), a multiyear agreement to accelerate therapeutic development through large ...

Illumina Inc. says it can read a person's entire genetic code for as little as $200 with its new sequencing machine, bringing the company within reach of its long-promised goal of the $100 genome.